Buscar en
Allergologia et Immunopathologia
Toda la web
Inicio Allergologia et Immunopathologia VI nerve palsy after intravenous immunoglobulin in Kawasaki disease
Journal Information
Vol. 42. Issue 1.
Pages 82-83 (January - February 2014)
Share
Share
Download PDF
More article options
Visits
2068
Vol. 42. Issue 1.
Pages 82-83 (January - February 2014)
Research letter
Full text access
VI nerve palsy after intravenous immunoglobulin in Kawasaki disease
Visits
2068
A. Rodríguez-Lozanoa, J.C. Juárez-Echeniqueb, F. Rivas-Larrauria, L.B. Gámez-Gonzáleza, M. Yamazaki-Nakashimadaa,
Corresponding author
yzki71@yahoo.com.mx

Corresponding author.
a Clinical Immunology Department, Instituto Nacional de Pediatría, Mexico City, Mexico
b Ophthalmology Department, Instituto Nacional de Pediatría, Mexico City, Mexico
This item has received
Article information
Full Text
Bibliography
Download PDF
Statistics
Full Text
To the Editor,

Kawasaki disease (KD) is an acute panvasculitis with special affinity for the coronary arteries. Diagnosis requires unexplained fever and at least four of five additional features.1 These features include: bilateral conjunctival injection; red, dry, fissured lips, injected oropharynx or cervical lymphadenopathy; and oedema, erythema and desquamation of the digits and of palmar and plantar surfaces of hands and feet.1 The most common ophthalmologic manifestations of KD are bilateral conjunctival injection and non-granulomatous iridocyclitis.2,3 Sixth nerve palsy is a recognized yet uncommon manifestation reported in KD. Interestingly, all the cases to date have been associated after IVIG infusion. We report a case of a patient with KD who presented VI nerve palsy after IVIG infusion and review the literature.

Case report

A six-year-old Mexican boy was admitted to the emergency department with a five-day history of fever and a maculopapular rash. The rash began on his back and thighs and later spread to cover the entire body. He also presented abdominal pain, vomiting and diarrhoea. On physical examination the patient presented bilateral non-exudative conjunctivitis, dry red lips, injected pharynx, and confluent, erythematous, papular rashes over the face, trunk, and limbs. There were no hepatosplenomegaly, lymphadenopathy or extremity changes. Neurologic examination was unremarkable.

Laboratory tests showed Hb 11g/dl, white blood cell count was 3700mm−3, 90% segmented neutrophils, 6% lymphocytes, and 148,000mm−3 platelets. Erythrocyte sedimentation rate was 18mm/h with a normal urinalysis.

He was hospitalized with a diagnosis of incomplete Kawasaki disease (fever and three of the five criteria: conjunctivitis, change in mucous membranes and rash) and an echocardiography was performed, which was reported normal. The patient was treated with intravenous immunoglobulin (2g/kg) and aspirin. Fever subsided one day after the initiation of immunoglobulin. On day 6 the patient started with bilateral skin peeling of his hands and feet. At this point, the patient fulfilled the AHA 2004 classic clinical criteria. The ophthalmologic evaluation showed normal pupillary light reactions, with visual acuities in the right eye 20/50 and in the left eye 20/50, with tortuosity of the retinal vessels consistent with bilateral ocular vasculitis.

On day 5 the patient complained of double vision. Neurological examination revealed a right sixth cranial nerve palsy. Cerebral magnetic resonance was performed which did not show abnormal findings. A fluorescein angiography was performed which showed mild leakage suggestive of vasculitis. The patient's condition improved but cranial nerve palsy persisted. Oral corticosteroids were added (oral prednisone 0.5mg/kg/day) with improvement of the ocular symptomatology and the patient was discharged on the 18th day.

Discussion

Kawasaki disease is one of the most common types of pediatric vasculitis. Neurological manifestations of KD are common and diverse with irritability, lethargy, and aseptic meningitis being the most frequent.1 Acute and subacute encephalopathy, seizures, cerebral infarction, ataxia, myositis, and lower motor neuron facial nerve palsy have also been described.1 Facial nerve palsy has been associated with increased mortality.4 The most common ophthalmologic manifestations of KD are bilateral conjunctival injection and non-granulomatous iridocyclitis. Ocular evaluation with slit-lamp examination has been suggested as a part of the work-up in doubtful cases. Other ocular manifestations that have been described include punctate keratitis, vitreous opacities, optic disc swelling, retinal ischemia, vascular occlusion, orbital myositis, and periorbital vasculitis.5–9

Two previous cases of KD and VI nerve palsy have been described.10,11 Guven et al. report a 12-year-old female with KD and sixth-nerve palsy who was treated with steroids and aspirin.10 Wurzburger et al. reported a seven-year-old female who presented with fever, rash, neck pain, conjunctival injection and dry red lips.11 She presented with vomiting, headache and Brudzinski's sign suggestive of aseptic meningitis. Slit examination was normal. Wurzburger hypothesized that the findings of the sixth cranial nerve palsy could be secondary to a vasculopathic phenomenon.11 Although in our case ocular vasculitis was documented, the development of VI nerve palsy cannot be explained by this finding alone. It is important to note that all the cases reported so far of KD complicated with VI nerve palsy have presented after IVIG infusion. Of note is one previous case of abducens nerve palsy following IVIG administration reported in a patient without KD. Wright et al. describe a 42-year-old female who received IVIG after renal transplantation for humoral rejection. She developed aseptic meningitis and VI nerve palsy.12 The authors hypothesize that perineuritis due to adjacent meningeal inflammatory reaction was the mechanism behind the abducens nerve palsy.12 Abducens nerve palsy has also been reported as a result of pachymeningitis in Wegener granulomatosis.13 We cannot rule out that this complication could be related to the IVIG infusion. Oral corticosteroids were used by Guven and us with subsequent tapering without complications. The cases reported so far have recovered without sequelae. It is essential for clinicians to be aware of the full spectrum of ocular involvement when assessing patients with KD and consider VI nerve palsy as a possible complication of IVIG.

Ethical disclosuresPatients’ data protection

The authors declare that they have followed the protocols of their work centre on the publication of patient data and that all the patients included in the study have received sufficient information and have given their informed consent in writing to participate in that study.

Right to privacy and informed consent

The authors declare that no patient data appear in this article.

Protection of human subjects and animals in research

The authors declare that no experiments were performed on humans or animals for this investigation.

References
[1]
J.W. Newburger, M. Takahashi, M.A. Gerber, M.H. Gewitz, L.Y. Tani, J.C. Burns, et al.
Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic fever, Endocarditis and Kawasaki disease, Council on Cardiovascular Disease in the Young, American Heart Association.
Circulation, 110 (2004), pp. 2742-2771
[2]
S. Ohno, T. Miyajima, M. Higuchi, A. Yoshida, H. Matsuda, Y. Saheki, et al.
Ocular manifestations of Kawasaki disease.
Am J Ophthalmol, 93 (1982), pp. 713-717
[3]
A.N. Blatt, L. Vogler, L. Tychsen.
Incomplete presentations in a series of 37 children with Kawasaki disease: the role of the pediatric ophtalmologist.
J Pediatr Ophthalmol Strabismus, 33 (1996), pp. 114-119
[4]
H. Wright, C. Waddington, J. Geddes, J.W. Newburger, D. Burgner.
Facial nerve palsy complicating Kawasaki disease.
Pediatrics, 122 (2008), pp. e783
[5]
M. Farvardin, S. Kashef, S. Aleyasin, S. Hesameddin Nabavizadeh, M. Sajjadi, M. Safari.
Sudden unilateral blindness in a girl with Kawasaki disease.
J Pediatr Ophthalmol Strabismus, 44 (2007), pp. 303-304
[6]
S. Anand, Y.C. Yang.
Optic disc changes in Kawasaki disease.
J Pediatr Ophthalmol Strabismus, 41 (2004), pp. 177-179
[7]
H. Lin, E.W. Burton, M.W. Felz.
Orbital myositis due to Kawasaki's disease.
Pediatr Radiol, 29 (1999), pp. 634-636
[8]
A. Kadayan, J. Choi, M.P. Headan.
Disciform keratitis and optic disc swelling in Kawasaki disease: an unusual presentation.
[9]
V. Purvin, A. Kawasaki, D.M. Jacobson.
Optic perineuritis: clinical and radiographic features.
Arch Ophtalmol, (2001), pp. 1299-1306
[10]
B.J. Wurzburger, J.R. Avner.
Lateral rectus palsy in Kawasaki disease.
Pediatr Infect Dis J, 18 (1999), pp. 1029-1031
[11]
B. Guven, V. Tavli, T. Mese, M.M. Yilmazer, M. Aydogan.
Isolated abducens palsy in adolescent girl with Kawasaki disease.
Pediatr Int, 52 (2010), pp. 334
[12]
S.E. Wright, Z.H.A. Shaikh, J.A. Castillo-Lugo, B. Tanriover.
Aseptic meningitis and abducens nerve palsy as a serious side effect of high dose intravenous immunoglobulin used in a patient with renal transplantation.
Transpl Infect Dis, 10 (2008), pp. 294-297
[13]
T. Kamimura, H. Shimazaki, M. Morita, I. Nakano, H. Okazaki, S. Minota.
Limited Wegener's granulomatosis manifested by abducens nerve palsy resulting from pachymeningitis.
J Clin Rheumatol, 12 (2006), pp. 259-260
Copyright © 2012. SEICAP
Article options
Tools
es en pt

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?

Você é um profissional de saúde habilitado a prescrever ou dispensar medicamentos